Disc Medicine, Inc. (IRON)
67.74
+0.21
(+0.31%)
USD |
NASDAQ |
May 08, 11:50
Disc Medicine Research and Development Expense (Annual) : 170.36M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Amylyx Pharmaceuticals, Inc. | 89.88M |
| Eli Lilly & Co. | 13.34B |
| Masimo Corp. | 126.40M |
| Cytokinetics, Inc. | 405.90M |
| Regeneron Pharmaceuticals, Inc. | 5.306B |